OCX-071

N/A

Report date: 2025/01/26 17:31:22
NME

Base Information

Drug NameOCX-071
Drug Alias NameOCX-071
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOcular inflammationCorneal fibrosisRetinal Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOccuRx Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOccuRx Pty Ltd
Inactive CompaniesN/A
Active IndicationsOcular inflammationCorneal fibrosisRetinal Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A